Abil Chempharma Pvt. Ltd. Rating Rationales / Reports

Title MID: 90702 16-May-2025 Issuer did not cooperate; Based on best available information; View Report MID: 79882 22-May-2024 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B -; Short Term Rating Reaffirmed; View Report MID: 71863 23-May-2023 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B; View Report MID: 60721 23-May-2022 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B +; Short Term Rating Reaffirmed; View Report MID: 49150 21-May-2021 Issuer did not cooperate; Based on best available information; Outstanding Ratings Downgraded; View Report MID: 33734 13-Dec-2019 Issuer did not cooperate; Based on best available information; Outstanding Ratings Downgraded; View Report MID: 18769 18-May-2017 Long Term Rating Upgraded to BWR BBB; Short Term Rating Reaffirmed; View Report MID: 11602 04-Nov-2015 Long Term Rating BWR BBB -/Stable Assigned; Short Term Rating BWR A3 Assigned; View Report